Search Results

There are 16094 results for: content related to: TRIPS -plus Border Measures and Access to Medicines

  1. Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 2, Summer 2012, Pages: 326–347, Jonathan Liberman

    Version of Record online : 12 JUL 2012, DOI: 10.1111/j.1748-720X.2012.00667.x

  2. Keeping it real: anticounterfeiting strategies in the pharmaceutical industry

    Managerial and Decision Economics

    Volume 29, Issue 5, July 2008, Pages: 389–405, Kristina M. Lybecker

    Version of Record online : 19 MAR 2008, DOI: 10.1002/mde.1405

  3. Intellectual Property and Economic Development in Sub-Saharan Africa

    The Journal of World Intellectual Property

    Volume 14, Issue 3-4, July 2011, Pages: 238–264, Michael Blakeney and Getachew Mengistie

    Version of Record online : 14 APR 2011, DOI: 10.1111/j.1747-1796.2011.00417.x

  4. Anticounterfeiting Strategies and Their Influence on Attitudes of Different Counterfeit Consumer Types

    Psychology & Marketing

    Volume 32, Issue 8, August 2015, Pages: 842–859, Ram Herstein, Netanel Drori, Ron Berger and Bradley R. Barnes

    Version of Record online : 7 JUL 2015, DOI: 10.1002/mar.20822

  5. Framing the National Interest: Debating Intellectual Property and Access to Essential Medicines in Kenya

    The Journal of World Intellectual Property

    Volume 17, Issue 1-2, March 2014, Pages: 16–33, John Harrington and Alasdair O'Hare

    Version of Record online : 21 JUL 2014, DOI: 10.1002/jwip.12020

  6. Watch out: Themes in timepiece communities of counterfeit consumption

    Journal of Consumer Behaviour

    Volume 12, Issue 4, July/August 2013, Pages: 307–317, Thomas M. Key, Robert E. Boostrom Jr., Mavis T. Adjei and David A. Campbell

    Version of Record online : 25 JUN 2013, DOI: 10.1002/cb.1431

  7. Unfettered Consumer Access to Affordable Therapies in the Post-TRIPS Era: A Dead-End Journey for Patients? Kenya and India Case Studies

    The Journal of World Intellectual Property

    Volume 13, Issue 3, May 2010, Pages: 403–473, Brenda Pamela Mey

    Version of Record online : 7 JAN 2010, DOI: 10.1111/j.1747-1796.2009.00392.x

  8. Rx Roulette: combatting counterfeit pharmaceuticals in developing nations

    Managerial and Decision Economics

    Volume 28, Issue 4-5, June - August 2007, Pages: 509–520, Kristina M. Lybecker

    Version of Record online : 17 AUG 2007, DOI: 10.1002/mde.1359

  9. China—Intellectual Property Rights: Implications for the TRIPS-Plus Border Measures

    The Journal of World Intellectual Property

    Volume 13, Issue 5, September 2010, Pages: 620–638, Henning Grosse Ruse-Khan

    Version of Record online : 27 JUL 2010, DOI: 10.1111/j.1747-1796.2010.00405.x

  10. Articles 7 and 8 of the TRIPS Agreement: A Force for Convergence within the International IP System

    The Journal of World Intellectual Property

    Volume 14, Issue 6, November 2011, Pages: 413–440, Alison Slade

    Version of Record online : 12 OCT 2011, DOI: 10.1111/j.1747-1796.2011.00429.x

  11. Assessing the problem of counterfeit medications in the United Kingdom

    International Journal of Clinical Practice

    Volume 66, Issue 3, March 2012, Pages: 241–250, G. Jackson, S. Patel and S. Khan

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1742-1241.2011.02826.x

  12. ‘Faking brands’: Consumer responses to counterfeiting

    Journal of Consumer Behaviour

    Volume 12, Issue 3, May/June 2013, Pages: 159–170, Nicolas Hamelin, Sonny Nwankwo and Rachad El Hadouchi

    Version of Record online : 7 DEC 2012, DOI: 10.1002/cb.1406

  13. How ethics influence intentions to buy counterfeit drugs: perceptions of policymakers, community pharmacists and consumers in Sudan

    Journal of Pharmaceutical Health Services Research

    Volume 5, Issue 3, September 2014, Pages: 181–186, Abubakr A. Alfadl, Mohamed Izham M. Ibrahim and Mohamed Azmi A. Hassali

    Version of Record online : 4 AUG 2014, DOI: 10.1111/jphs.12062

  14. Consumer behaviour towards counterfeit drugs in a developing country

    Journal of Pharmaceutical Health Services Research

    Volume 3, Issue 3, September 2012, Pages: 165–172, Abubakr A. Alfadl, Mohamed Izham M. Ibrahim and Mohamed A. Hassali

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1759-8893.2012.00095.x

  15. The global counterfeit drug trade: Patient safety and public health risks

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 11, November 2011, Pages: 4571–4579, Tim K. Mackey and Bryan A. Liang

    Version of Record online : 22 JUN 2011, DOI: 10.1002/jps.22679

  16. Keeping Pace with Counterfeiters

    The Journal of World Intellectual Property

    Volume 5, Issue 6, November 2002, Pages: 965–979, Philip Gordon

    Version of Record online : 1 NOV 2005, DOI: 10.1111/j.1747-1796.2002.tb00188.x

  17. The economics of counterfeit Avastin: a geospatial and statistical analysis of demographic correlates to FDA warning letters

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 7, July 2015, Pages: 748–756, Raphael E. Cuomo, Tim K. Mackey and Paula Stigler

    Version of Record online : 27 MAY 2015, DOI: 10.1002/pds.3796

  18. Brand Management and Strategies Against Counterfeits

    Journal of Economics & Management Strategy

    Volume 23, Issue 2, Summer 2014, Pages: 317–343, Yi Qian

    Version of Record online : 4 APR 2014, DOI: 10.1111/jems.12057

  19. Consumer demand for counterfeit goods

    Psychology & Marketing

    Volume 15, Issue 5, August 1998, Pages: 405–421, Gail Tom, Barbara Garibaldi, Yvette Zeng and Julie Pilcher

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1520-6793(199808)15:5<405::AID-MAR1>3.0.CO;2-B

  20. Availability of Medicines Online and Counterfeit Medicines

    The Textbook of Pharmaceutical Medicine, 7th Edition

    Ruth Diazaraque, David Gillen, Pages: 597–609, 2013

    Published Online : 25 APR 2013, DOI: 10.1002/9781118532331.ch30